Skip to content
Screener

Arbutus Biopharma Corporation ABUS Q4 2025 Annual earnings

Reported March 23, 2026 · Before market open

Revenue$1.1MBeat by $436.5K
EPS-$0.01Beat by $0.03
Revenue estimate$614.5K
EPS estimate-$0.04

Next report

Nov 16, 2026 (in a month)
Revenue estimate$1.0M
EPS estimate-$0.02

Financials

Q4 2025

Income statement

See full
Revenue$1.1M-33.2%
Operating income-$5.3M+62.0%
Net income-$3.8M+70.0%
EPS (diluted)-$0.01+85.7%

Balance sheet

See full
Cash & equivalents$18.0M-50.4%
Total debt$746.0K-42.1%
Total equity$76.6M-21.4%
Total assets$94.6M-28.2%

Cash flow

See full
Operating cash flow-$4.7M+54.6%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$925.08M+49.3%
Enterprise value$907.82M+55.3%
P/S65.7×-34.7×

Profitability

See full
Operating margin-271%-119pp
Net margin-237.9%-105pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity-38.5%-11.8pp
Debt / equity0×0.0×
Current ratio15.7×+7.6×

Segments

By product

See full
Non-cash royalty revenue$259.0K-49.8%
Revenue from collaborations and licenses--100%

By segment

See full
Reportable Segment$1.1M-33.2%

FAQ

When did Arbutus Biopharma Corporation report Q4 2025 earnings?
Arbutus Biopharma Corporation (ABUS) reported Q4 2025 earnings on March 23, 2026 before market open.
What were Arbutus Biopharma Corporation's Q4 2025 revenue and EPS?
Arbutus Biopharma Corporation reported revenue of $1.1M and eps of $-0.01 for Q4 2025.
Did Arbutus Biopharma Corporation beat estimates in Q4 2025?
Revenue beat the consensus estimate of $614.5K by $436.5K. EPS beat the consensus estimate of $-0.04 by $0.03.
How did Arbutus Biopharma Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 33.2% from $1.6M a year earlier and eps grew 85.7% from $-0.07.
Where can I find Arbutus Biopharma Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-001838) and the 10-K periodic report (0001447028-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.